Chevy Chase Trust Holdings, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Chevy Chase Trust Holdings, Inc.
- $32.3 Billion
- Q3 2024
A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 238,379 shares of REGN stock, worth $167 Million. This represents 0.78% of its overall portfolio holdings.
Number of Shares
238,379
Previous 241,754
1.4%
Holding current value
$167 Million
Previous $254 Million
1.38%
% of portfolio
0.78%
Previous 0.82%
Shares
30 transactions
Others Institutions Holding REGN
# of Institutions
1,534Shares Held
83.6MCall Options Held
1.22MPut Options Held
1.51M-
Vanguard Group Inc Valley Forge, PA9.32MShares$6.54 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.93 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.26 Billion0.65% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.44 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$3.02 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $75.2B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...